08049.HK
Jilin Province Huinan Changlong Bio-pharmacy Company Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 2.65
−1.85%Margins
Gross margin
84.6%
EBITDA margin
30.0%
EBIT margin
26.1%
Net margin
25.1%
FCF margin
0.0%
15.4%
Return on equity
10.2%
Return on assets
16.0%
Return on invested capital
0.41x
Asset turnover
HKD 0.00
Cash from operations
HKD 1.89
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026